REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
FOR |
|
PUMA BIOTECHNOLOGY LTD |
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
FOR |
|
PUMA BIOTECHNOLOGY LTD |
PUMA BIOTECHNOLOGY LTD (REGISTERED NUMBER: 08277417) |
|
|
|
|
|
|
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Balance Sheet | 2 |
|
Notes to the Financial Statements | 3 |
|
PUMA BIOTECHNOLOGY LTD |
|
COMPANY INFORMATION |
FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
|
|
|
|
|
|
DIRECTOR: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
AUDITORS: |
|
Lower Ground Floor |
111 Charterhouse Street |
London |
EC1M 6AW |
PUMA BIOTECHNOLOGY LTD (REGISTERED NUMBER: 08277417) |
|
BALANCE SHEET |
31 DECEMBER 2020 |
|
2020 | 2019 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 4 |
|
|
Cash at bank |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 5 | ( |
) | ( |
) |
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
CAPITAL AND RESERVES |
Called up share capital |
|
|
Retained earnings |
|
|
|
|
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
|
The financial statements were approved by the director and authorised for issue on
|
|
|
|
|
|
|
|
PUMA BIOTECHNOLOGY LTD (REGISTERED NUMBER: 08277417) |
|
NOTES TO THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
1. | STATUTORY INFORMATION |
|
Puma Biotechnology Ltd is a
|
|
The presentation currency of the financial statements is the Pound Sterling (£). |
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover represents income earned from the parent, Puma Biotechnology Inc. based on a cost plus agreement, excluding Value Added Tax. |
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognized in the Income Statement, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognized at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
|
Pension costs and other post-retirement benefits |
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
|
3. | EMPLOYEES AND DIRECTORS |
|
The average number of employees during the year was
|
|
4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2020 | 2019 |
£ | £ |
Amounts owed by group undertakings |
|
|
VAT |
|
|
Deferred tax asset |
|
|
|
|
PUMA BIOTECHNOLOGY LTD (REGISTERED NUMBER: 08277417) |
|
NOTES TO THE FINANCIAL STATEMENTS - continued |
FOR THE YEAR ENDED 31 DECEMBER 2020 |
|
5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
2020 | 2019 |
£ | £ |
Tax |
|
|
Social security and other taxes |
|
|
Accrued expenses |
|
|
|
|
|
6. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
|
The Report of the Auditors was unqualified. |
|
|
for and on behalf of
|
|
7. | RELATED PARTY DISCLOSURES |
|
The company is a wholly owned subsidiary of Puma Biotechnology, Inc. |
|
During the period the company invoiced services to its parent company, Puma Biotechnology, Inc., amounting to £56,852 (2019: £86,355). |
|
As at 31 December 2020 an amount of £31,499 (2019: £27,341) was owed to the company from Puma Biotechnology, Inc. |
|
8. | ULTIMATE CONTROLLING PARTY |
|
The ultimate controlling party is Puma Biotechnology, Inc. Incorporated in the state of Delaware, USA with the registered address 10880 Wilshire Boulevard, Suite 2150, Los Angeles, CA 90024. |